Roivant Sciences

Yahoo Finance • 2 months ago

Is Roivant Sciences Ltd. (ROIV) the Best Guru Stock To Buy Now?

We recently compiled a list of the 10 Best Guru Stocks To Buy Now. In this article, we will have a look at where Roivant Sciences Ltd. (NASDAQ:ROIV) ranks among the best guru stocks to buy now. Due to the plethora of investment options su... Full story

Yahoo Finance • 2 months ago

Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

Roivant Sciences VTAMA cream is a novel, non-steroidal topical therapy approved for treatment of plaque psoriasis in adults and is under FDA review for an additional indication to treat atopic dermatitis Proposed acquisition extends Orga... Full story

Yahoo Finance • 2 months ago

Roivant Sciences Unveils New 'Vant' Subsidiary For In-Licensed Pulmonary Hypertension Drug From Bayer

Roivant Sciences Unveils New 'Vant' Subsidiary For In-Licensed Pulmonary Hypertension Drug From Bayer Tuesday, Roivant Sciences Ltd. (NASDAQ:ROIV) created Pulmovant to in-license from Bayer AG (OTC:BAYRY) exclusive worldwide rights to dev... Full story

Yahoo Finance • 3 months ago

The Federal Reserve should refresh its mandate: Former presidential candidate Vivek Ramaswamy

The Federal Reserve’s dual mandate to promote maximum employment and stable prices should be tweaked, proclaimed former Republican presidential candidate Vivek Ramaswamy. "I personally believe the right policy is dollar stability — make t... Full story

Yahoo Finance • 6 months ago

Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provide Business Update on Thursday, May 30, 2024

Roivant Sciences BASEL, Switzerland and LONDON and NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 30, 2024, to report... Full story

Yahoo Finance • 10 months ago

16 Best Mid Cap Growth Stocks To Buy Now

In this article, we will take a detailed look at the16Best Mid-Cap Growth Stocks To Buy Now. For a quick overview of such stocks, read our article 5Best Mid-Cap Growth Stocks To Buy Now. Investors are hopeful that small- and mid-cap stock... Full story

Yahoo Finance • 11 months ago

12 High Growth International Stocks to Buy

In this article, we discuss the 12 high growth international stocks to buy. If you want to read about some more high growth international stocks, go directly to 5 High Growth International Stocks to Buy. There is general optimism on Wall... Full story

Yahoo Finance • 11 months ago

13 High Growth Healthcare Stocks to Buy

In this article, we will take a look at 13 high growth healthcare stocks to buy. To skip our analysis of the recent market activity, you can go directly to see the 5 Best High Growth Healthcare Stocks to Buy. For the purpose of this artic... Full story

Yahoo Finance • 11 months ago

13 Most Promising Low-Cost Stocks According to Analysts

In this article, we will take a look at 13 most promising low-cost stocks according to analysts. To skip our analysis of the recent market activity, you can go directly to see the 5 Most Promising Low-Cost Stocks According to Analysts. Fo... Full story

Yahoo Finance • 12 months ago

Roivant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class Potential

Results from the 600 mg MAD cohort for IMVT-1402 similar to previously disclosed results from the 300 mg MAD cohort for IMVT-1402 IMVT-1402 was observed to deliver dose dependent and deep IgG reductions similar to batoclimab in its Phase 1... Full story

Yahoo Finance • 12 months ago

Roivant and Priovant Announce Results from Phase 2 Study of Oral Brepocitinib in Systemic Lupus Erythematosus

Oral brepocitinib failed to meet its primary endpoint of Systemic Lupus Erythematosus Responder Index (SRI-4) change of 4 at Week 52Priovant plans to continue progressing the program in indications outside of Systemic Lupus Erythematosus (... Full story

Yahoo Finance • last year

11 Best Undervalued UK Stocks To Buy Now

In this piece, we will take a look at the 11 best undervalued U.K. stocks to buy now. If you want to skip our overview of the British economy, then take a look at 5 Best Undervalued UK Stocks To Buy Now. The U.K. is one of the biggest eco... Full story

Yahoo Finance • last year

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2023, and Provides Business Update

Roivant entered into a definitive agreement with Roche for the sale of Telavant for $7.1B upfront and a milestone payment of $150M payable upon the initiation of a Phase 3 trial in ulcerative colitis IMVT-1402 subcutaneous (SC) doses achie... Full story

Yahoo Finance • last year

Roivant Announces Appointment of Mayukh Sukhatme to Its Board of Directors

BASEL, Switzerland and LONDON and NEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced the appointment of Mayukh Sukhatme, M.D., to its Board of Directors, effective immediately. Dr. Sukhatme will fill a new... Full story

Yahoo Finance • last year

Roche Enters Into a Definitive Agreement to Acquire Telavant Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of Inflammatory Bowel Disease From Roivant

Roche will gain the rights to develop, manufacture and commercialize RVT-3101 in the US and Japan for the treatment of inflammatory bowel disease and potentially multiple other diseasesRVT-3101 is a Phase 3-ready antibody with first-in-cla... Full story

Yahoo Finance • last year

13 Stocks to Buy with Exponential Growth

In this article, we will take a look at the 13 stocks to buy with exponential growth. To see more such companies, go directly to 5 Stocks to Buy with Exponential Growth. Optimism was prevailing in the US stock market on October 11 as inve... Full story

Yahoo Finance • last year

Covant Therapeutics Appoints Vincent Hennemand as Chief Executive Officer

BOSTON, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Covant Therapeutics, an innovative covalent drug discovery company, is pleased to announce the appointment of Vincent Hennemand as Chief Executive Officer (CEO). Vincent Hennemand is a seasoned... Full story

Yahoo Finance • last year

Lokavant Announces $8M Strategic Investment from Mitsui & Co. to Expand AI and Predictive Clinical Trial Intelligence into Asia-Pacific

NEW YORK, October 03, 2023--(BUSINESS WIRE)--Lokavant, the clinical trial intelligence platform company, today announces an $8 million strategic investment from global business titan Mitsui & Co. Ltd. to expand its AI-optimized platform ac... Full story

Yahoo Finance • last year

Roivant Announces Positive Initial IMVT-1402 Phase 1 SAD and 300 mg Subcutaneous MAD Results

IMVT-1402 subcutaneous (SC) doses achieved peak Immunoglobulin G (IgG) reductions that are similar to those previously observed with batoclimabNo decrease in serum albumin below baseline or increase in low-density lipoprotein cholesterol (... Full story

Yahoo Finance • last year

Roivant Announces Redemption Fair Market Value in Connection with Redemption of its Outstanding Warrants

BASEL, Switzerland and LONDON and NEW YORK, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced the “Redemption Fair Market Value” to be used in connection with the previously announced redemption of its outstanding... Full story